Monoclonal antibody facility

Monoclonal Antibody FacilityThe Perkins Monoclonal Antibody Facility produces pure antibodies needed for medical or research purposes. Researchers and biotechnology companies have access to the custom-made antibodies necessary to develop new products such as diagnostic tools.  Monoclonal antibodies have been used to successfully treat breast cancer, lymphoma, rheumatoid arthritis, asthma, leukaemia and in transplants to minimise the chances of organ rejection.


Back To Top